Telehealth prescribing models in the US posts 61–90

Picking up post #72: that is the part I would want checked first.

If you are new and reading this thread for the answer to telehealth prescribing models: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth skipping.

A telehealth route and an in-person route can reach the same prescription through different criteria, and the criteria are what generalise.

I have said this before in a thread nobody could find, so it is worth repeating.

Prior authorisation criteria are usually published by the payer and reading them before the appointment changes the outcome more than anything else does.

Old habit: I write down the expected answer before I calculate it.

Where the telehealth prescribing models discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.

United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans, not nationally.

A qualification I should have led with rather than closed on.

Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current.

Reporting the observation and leaving the explanation open deliberately.

The reason telehealth prescribing models is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.

Post #79 answers the question as asked. The question underneath it is different.

Telehealth prescribing models: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.

My understanding of telehealth prescribing models is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

The claim about telehealth prescribing models upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

Reading rather than answering, but this is the post I would point somebody at.

Post #83 put the caveat in the right place and I want to underline it.

Both are useful and different. The account tells you what happens in practice; the criterion tells you what to write.

Not the answer, but possibly the question that gets there.

Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.

I had written a reply contradicting post #87 and deleted it. Here is what survived.

Reframing telehealth prescribing models slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.

The documentation on telehealth prescribing models is better than this thread and I say that as someone who has posted in the thread.